ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TSHA Company Profile and Key Details

NASDAQ : TSHA

Taysha Gene Therapies, Inc.

$1.75

0.06+3.55%

At Close 4:00 PM

63.82

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

TSHA Stock Price Chart

Stock Price Today

Taysha Gene Therapies, Inc. (TSHA) stock surged +3.55%, trading at $1.75 on NASDAQ, up from the previous close of $1.69. The stock opened at $1.65, fluctuating between $1.65 and $1.77 in the recent session.

Stock Snapshot

1.69

Prev. Close

1.65

Open

358.75M

Market Cap

205M

Number of Shares

1.65

Day Low

1.765

Day High

-4.86

P/E Ratio

76.93%

Free Float in %

-0.36

EPS (TTM)

0.4

Book Value

-0.43

Cash Flow per Share

1.16M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	1.65	1.77	1.65	1.75	1.16M
Mar 06, 2025	1.70	1.80	1.65	1.69	1.32M
Mar 05, 2025	1.64	1.74	1.63	1.70	1.47M
Mar 04, 2025	1.59	1.67	1.57	1.63	1.6M
Mar 03, 2025	1.60	1.66	1.59	1.62	2.88M
Feb 28, 2025	1.59	1.64	1.58	1.60	952.06K
Feb 27, 2025	1.60	1.73	1.59	1.59	2.37M
Feb 26, 2025	1.80	1.89	1.59	1.62	2.12M
Feb 25, 2025	1.66	1.74	1.63	1.70	2.1M
Feb 24, 2025	1.61	1.68	1.60	1.65	1.37M
Feb 21, 2025	1.64	1.71	1.60	1.61	1.64M
Feb 20, 2025	1.65	1.70	1.60	1.64	977.91K
Feb 19, 2025	1.62	1.67	1.58	1.64	1.19M
Feb 18, 2025	1.64	1.74	1.58	1.60	2.44M
Feb 14, 2025	1.63	1.76	1.59	1.63	1.21M
Feb 13, 2025	1.59	1.66	1.55	1.62	1.12M
Feb 12, 2025	1.60	1.60	1.46	1.60	1.98M
Feb 11, 2025	1.85	1.85	1.50	1.60	3.05M
Feb 10, 2025	1.75	1.88	1.70	1.87	3.19M
Feb 07, 2025	1.70	1.83	1.67	1.75	3.24M

Contact Details

Dallas, TX 75247

United States

Website: https://www.tayshagtx.comContact: 214 612 0000

About Company

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.

Frequently Asked Questions

What is the current Taysha Gene Therapies, Inc. (TSHA) stock price?

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) stock price is $1.75 in the last trading session. During the trading session, TSHA stock reached the peak price of $1.77 while $1.65 was the lowest point it dropped to. The percentage change in TSHA stock occurred in the recent session was 3.55% while the dollar amount for the price change in TSHA stock was $0.06.

TSHA's industry and sector of operation?

The NASDAQ listed TSHA is part of Biotechnology industry that operates in the broader Healthcare sector. Taysha Gene Therapies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TSHA?

Dr. Steven Gray Ph.D.
Chief Scientific Advisor of UT Southwestern Gene Therapy Program
Dr. Sukumar Nagendran M.D.
Pres, Head of R&D and Director
Dr. Suyash Prasad F.F.P.M, FFPM, M.B.B.S., M.D., M.Sc., MBBS
Chief Medical Officer
Mr. Jim Rouse
Chief Information Officer
Ms. Tracy M. Porter
Chief People Officer
Mr. Kamran Alam C.P.A., M.B.A.
Chief Financial Officer & Corporation Sec.
Ms. Tracy M. Porter SPHR
Chief People Officer
Mr. Sean P. Nolan
Chief Executive Officer & Chairman
Mr. R. A. Session II
Founder, Pres, Chief Executive Officer & Director
Mr. Frederick Porter Ph.D.
Chief of Staff & Technical Operations Officer
Dr. Suyash Prasad FFPM, M.Sc., MBBS, M.D., M.B.B.S., F.F.P.M
Chief Medical Officer and Head of R&D
Mr. Sean McAuliffe
Chief Bus. Officer
Ms. Mishima Gerhart
Chief Regulatory Officer & Head of Quality
Mr. Greg Gara
Senior Vice President of Manufacturing
Berge Minassian M.D.
Chief Medical Advisor of UT Southwestern Gene Therapy Program
Mr. Kamran Alam CPA, M.B.A.
Chief Financial Officer & Corporation Sec.
Ms. Emily McGinnis M.P.H.
Chief Patient Advocacy & External Affairs Officer
Dr. Kimberly Lee D.O.
Chief Corporation Affairs Officer
Steven Gray Ph.D.
Chief Scientific Advisor of UT Southwestern Gene Therapy Program
Hayleigh Collins
Director & Head of Corporation Communications

How TSHA did perform over past 52-week?

TSHA's closing price is 47.06% higher than its 52-week low of $1.19 where as its distance from 52-week high of $4.32 is -59.49%.

How many employees does TSHA have?

Number of TSHA employees currently stands at 73.

Link for TSHA official website?

Official Website of TSHA is: https://www.tayshagtx.com

How do I contact TSHA?

TSHA could be contacted at phone 214 612 0000 and can also be accessed through its website. TSHA operates from 3000 Pegasus Park Drive, Dallas, TX 75247, United States.

How many shares of TSHA are traded daily?

TSHA stock volume for the day was 1.16M shares. The average number of TSHA shares traded daily for last 3 months was 2.27M.

What is the market cap of TSHA currently?

The market value of TSHA currently stands at $358.75M with its latest stock price at $1.75 and 205M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	73
Beta	0.89
Sales or Revenue	$15.45M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology